December 3, 2015 HILLSBOROUGH: “Don’t overlook incidence of hepatitis C and HIV”Read more

November 14, 2015 Merck Announces Presentation of Phase 3 Results of Investigational Elbasvir/Grazoprevir in People with Chronic Hepatitis C Genotypes 1, 4 or 6 Infection Who Inject Drugs and Are on Opioid Agonist TherapyRead more